[1] |
YOUNG KA, DILLING DF. The future of lung transplantation[J]. Chest, 2019, 155(3): 465-473. DOI: 10.1016/j.chest.2018.08.1036.
|
[2] |
MEYER KC. Recent advances in lung transplantation[J]. F1000Res, 2018, 7: F1000 Faculty Rev-1684. DOI: 10.12688/f1000research.15393.1.
|
[3] |
毛文君, 陈静瑜. 离体肺灌注技术的临床应用[J]. 器官移植, 2018, 9(5): 334-338. DOI:10.3969/j.issn. 1674-7445.2018.05.002.MAO WJ, CHEN JY. Clinical application of ex vivo lung perfusion[J]. Organ Transplant, 2018, 9(5): 334-338. DOI: 10.3969/j.issn.1674-7445.2018.05.002.
|
[4] |
TAN YB, PASTUKH VM, GORODNYA OM, et al. Enhanced mitochondrial DNA repair resuscitates transplantable lungs donated after circulatory death[J]. J Surg Res, 2020, 245: 273-280. DOI: 10.1016/j.jss.2019. 07.057.
|
[5] |
MACHUCA TN, CYPEL M. Ex vivo lung perfusion[J]. J Thorac Dis, 2014, 6(8): 1054-1062. DOI: 10.3978/j.issn. 2072-1439.2014.07.12.
|
[6] |
WONG A, ZAMEL R, YEUNG J, et al. Potential therapeutic targets for lung repair during human ex vivo lung perfusion[J]. Eur Respir J, 2020, 55(4): 1902222. DOI: 10.1183/13993003.02222-2019.
|
[7] |
STONE ML, SHARMA AK, MAS VR, et al. Ex vivo perfusion with adenosine A2A receptor agonist enhances rehabilitation of murine donor lungs after circulatory death[J]. Transplantation, 2015, 99(12): 2494-2503. DOI: 10.1097/TP.0000000000000830.
|
[8] |
NⅡKAWA H, OKAMOTO T, AYYAT KS, et al. Cellular ex vivo lung perfusion beyond 1 hour may improve marginal donor lung assessment[J]. J Surg Res, 2020, 250: 88-96. DOI: 10.1016/j.jss.2019.09.073.
|
[9] |
BELLER JP, BYLER MR, MONEY DT, et al. Reduced-flow ex vivo lung perfusion to rehabilitate lungs donated after circulatory death[J]. J Heart Lung Transplant, 2020, 39(1): 74-82. DOI: 10.1016/j.healun.2019.09.009.
|
[10] |
SARAIVA M, VIEIRA P, O'GARRA A. Biology and therapeutic potential of interleukin-10[J]. J Exp Med, 2020, 217(1): e20190418. DOI: 10.1084/jem.20190418.
|
[11] |
YEUNG JC, WAGNETZ D, CYPEL M, et al. Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation in the pig[J]. Mol Ther, 2012, 20(6): 1204-1211. DOI: 10.1038/mt.2012.57.
|
[12] |
MACHUCA TN, CYPEL M, BONATO R, et al. Safety and efficacy of ex vivo donor lung adenoviral IL-10 gene therapy in a large animal lung transplant survival model[J]. Hum Gene Ther, 2017, 28(9): 757-765. DOI: 10.1089/hum.2016.070.
|
[13] |
WEI D, GAO F, YANG Z, et al. Ex vivo lung perfusion with perfusate purification for human donor lungs following prolonged cold storage[J]. Ann Transl Med, 2020, 8(3): 38. DOI: 10.21037/atm.2019.10.17.
|
[14] |
TIAN D, SHⅡYA H, SATO M, et al. Rat lung transplantation model: modifications of the cuff technique[J]. Ann Transl Med, 2020, 8(6): 407. DOI: 10.21037/atm.2020.02.46.
|
[15] |
李梦倩, 李彬, 董铁立. 右美托咪定对大鼠离体肺缺血-再灌注损伤时RIPK3/MLKL介导程序性坏死的影响[J]. 临床麻醉学杂志, 2019, 35(9): 909-912. DOI: 10.12089/jca.2019.09.018LI MQ, LI B, DONG TL. Effects of dexmedetomidine on RIPK3/MLKL-mediated pulmonary necroptosis during isolated lung ischemia-reperfusion injury in rats[J]. J Clin Anesthesiol, 2019, 35(9): 909-912. DOI: 10.12089/jca.2019.09.018.
|
[16] |
SEF D, VERZELLONI SEF A, MOHITE P, et al. Utilization of extracorporeal membrane oxygenation in DCD and DBD lung transplants: a 2-year single-center experience[J]. Transpl Int, 2020, 33(12): 1788-1798. DOI: 10.1111/tri.13754.
|
[17] |
CHARLES EJ, HUNTER MEHAFFEY J, HUERTER ME, et al. Ex vivo assessment of porcine donation after circulatory death lungs that undergo increasing warm ischemia times[J]. Transplant Direct, 2018, 4(12): e405. DOI: 10.1097/TXD.0000000000000845.
|
[18] |
GU C, PAN X, SHI J. Progress of clinical application for ex vivo lung perfusion (EVLP) in lung transplantation[J]. Methods Mol Biol, 2020, 2204: 217-224. DOI: 10.1007/ 978-1-0716-0904-0_19.
|
[19] |
DIVITHOTAWELA C, CYPEL M, MARTINU T, et al. Long-term outcomes of lung transplant with ex vivo lung perfusion[J]. JAMA Surg, 2019, 154(12): 1143-1150. DOI: 10.1001/jamasurg.2019.4079.
|
[20] |
CHEN X, YANG B, TIAN J, et al. Dental follicle stem cells ameliorate lipopolysaccharide-induced inflammation by secreting TGF-β3 and TSP-1 to elicit macrophage M2 polarization[J]. Cell Physiol Biochem, 2018, 51(5): 2290-2308. DOI: 10.1159/000495873.
|
[21] |
OUYANG W, O'GARRA A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation[J]. Immunity, 2019, 50(4): 871-891. DOI: 10.1016/j.immuni. 2019.03.020.
|
[22] |
PIAZZON MC, LUTFALLA G, FORLENZA M. IL10, a tale of an evolutionarily conserved cytokine across vertebrates[J]. Crit Rev Immunol, 2016, 36(2): 99-129. DOI: 10.1615/CritRevImmunol.2016017480.
|
[23] |
WEI H, LI B, SUN A, et al. Interleukin-10 family cytokines immunobiology and structure[J]. Adv Exp Med Biol, 2019, 1172: 79-96. DOI: 10.1007/978-981-13-9367-9_4.
|
[24] |
EUFRÁSIO DE FIGUEIREDO WM, HEREDIA FF, SANTOS AS, et al. CXCL10 treatment promotes reduction of IL-10+ regulatory T (Foxp3+ and Tr1) cells in the spleen of Balb/c mice infected by Leishmania infantum[J]. Exp Parasitol, 2019, 207: 107789. DOI: 10.1016/j.exppara.2019.107789.
|
[25] |
BEDKE T, MUSCATE F, SOUKOU S, et al. IL-10-producing T cells and their dual functions[J]. Semin Immunol, 2019, 44: 101335. DOI: 10.1016/j.smim.2019. 101335.
|
[26] |
SUN L, HULT EM, CORNELL TT, et al. Loss of myeloid-specific protein phosphatase 2A enhances lung injury and fibrosis and results in IL-10-dependent sensitization of epithelial cell apoptosis[J]. Am J Physiol Lung Cell Mol Physiol, 2019, 316(6): L1035-L1048. DOI: 10.1152/ajplung.00299.2018.
|
[27] |
CHEN H, LIN W, LIN P, et al. IL-10 produces a dual effect on OGD-induced neuronal apoptosis of cultured cortical neurons via the NF-κB pathway[J]. Aging (Albany NY), 2019, 11(23): 10796-10813. DOI: 10.18632/aging.102411.
|